AMIX Autonomix Medical, Inc. - Common Stock
$6,43
Preço · Jul 2, 2026
Fundamentais a partir de Jun 15, 2026
Intervalo 52 Semanas
$0–$8
77% of range
Classificação do Analista
BUY
7 analysts
Preço-Alvo
$59
+814% upside
P/E (TTM)
—
ROE
—
Margem de Lucro Líquido
—
AMIX Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$6.43
Capitalização de Mercado
—
P/E (TTM)
—
EPS (TTM)
—
Receita (TTM)
$0
Rendimento div.
—
ROE
—
Dívida/Capital
—
Intervalo 52 Semanas
$0 – $8
AMIX Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$0
2023-03-31
→
2026-03-31
EPS
—
Fluxo de caixa livre
—
Margens
—
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
AMIX
Mediana de Pares
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
AMIX
Mediana de Pares
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
AMIX
Mediana de Pares
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
AMIX
Mediana de Pares
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
AMIX
Mediana de Pares
AMIX Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
7 analistas
- Compra forte 2 28,6%
- Compra 4 57,1%
- Manter 1 14,3%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
2 analistas · 2026-07-05
Mediana
$58.80
← Abaixo de todos os alvos
$6.43
Mín
$42.00
Máx
$75.60
Alvo mediano
$58.80
+814,5%
Alvo médio
$58.80
+814,5%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.97%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Dezembro de 2026 | $-0.23 | $-0.27 | — |
| 31 de Março de 2026 | $-4.83 | $-5.57 | 0.74% |
| 31 de Dezembro de 2025 | $-7.56 | $-12.53 | 5.0% |
| 30 de Setembro de 2025 | $-1.38 | $-1.13 | -0.25% |
| 30 de Junho de 2025 | $-1.07 | $-1.00 | -0.07% |
| 31 de Março de 2025 | $-1.81 | $-1.26 | -0.55% |
Comparação com pares Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| AMIX | — | — | — | — | — | — |
| XAIR | $8M | -0.2 | 107.3% | -433.0% | -337.4% | 3.3% |
| TNON | — | — | — | — | — | — |
| FEED | $3M | -0.1 | -0.20% | -712.3% | -49.2% | 6.0% |
| IVF | — | -0.0 | 4.7% | — | — | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 12
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | |
| R&D Expense | $7M | $5M | $2M | $745.0K | |
| SG&A Expense | $10M | $7M | $5M | $1M | |
| Operating Expenses | $17M | $12M | $12M | $2M | |
| Operating Income | $-17M | $-12M | $-12M | $-2M | |
| Interest Income | $319.0K | $354.0K | $127.0K | $0 | |
| Other Non-op | $319.0K | $178.0K | $-3M | $0 | |
| Pretax Income | $-17M | $-11M | $-15M | $-2M | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-17M | $-11M | $-15M | $-2M | |
| EPS (Basic) | $-2.32 | $-6.46 | $-14.82 | $-0.17 | |
| Shares (Basic) | 7,216,757 | 1,766,425 | 1,040,720 | 12,023,112 |
Balanço Patrimonial 18
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $9M | $9M | $865.0K | |
| Other Current Assets | $577.0K | $473.0K | $783.0K | $0 | |
| Current Assets | $8M | $10M | $9M | $865.0K | |
| PP&E (Net) | $19.0K | $21.0K | $16.0K | $0 | |
| Total Assets | $8M | $10M | $9M | $865.0K | |
| Accounts Payable | $700.0K | $676.0K | $492.0K | $173.0K | |
| Accrued Liabilities | $1M | $1M | $285.0K | $48.0K | |
| Short-term Debt | · | · | $0 | · | |
| Current Liabilities | $2M | $2M | $777.0K | $221.0K | |
| Other Non-current Liabilities | · | · | · | $0 | |
| Total Liabilities | $2M | $2M | $2M | $221.0K | |
| Long-term Debt | · | · | · | $0 | |
| Common Stock | $11.0K | $2.0K | $1.0K | $12.0K | |
| Paid-in Capital | $73M | $58M | $47M | $24M | |
| Retained Earnings | $-67M | $-50M | $-39M | $-24M | |
| Stockholders' Equity | $6M | $8M | $8M | $644.0K | |
| Liabilities + Equity | $8M | $10M | $9M | $865.0K | |
| Shares Outstanding | 11,409,344 | 2,497,033 | 942,575 | 12,336,571 |
Fluxo de Caixa 8
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| D&A | $12.0K | $183.0K | $81.0K | $0 | |
| Stock-based Comp | $529.0K | $2M | $618.0K | $0 | |
| Operating Cash Flow | $-12M | $-8M | $-7M | $-2M | |
| CapEx | $10.0K | $14.0K | $19.0K | $0 | |
| Investing Cash Flow | $-10.0K | $-14.0K | $-19.0K | $0 | |
| Stock Issued | $0 | $2.0K | $3M | $675.0K | |
| Financing Cash Flow | $10M | $9M | $14M | $675.0K | |
| Net Change in Cash | $-2M | $528.0K | $8M | $-1M |
Avaliação (TTM) 3
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | · | |
| Net Income TTM | $-17M | $-11M | $-15M | · | |
| P / Tangible Book | 0.8 | 0.5 | 149.2 | · |
Demonstração de Resultados 16
| Métrica | Tendência | Q4 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $954.0K | $699.0K | $687.0K | $471.0K | $368.0K | |
| SG&A Expense | $1M | $2M | $5M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $793.0K | $503.0K | |
| Operating Expenses | $3M | $3M | $8M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $6M | $871.0K | |
| Operating Income | $-3M | $-3M | $-8M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-6M | $-871.0K | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $33.0K | · | · | |
| Interest Income | $70.0K | $82.0K | $83.0K | $84.0K | $107.0K | $80.0K | $72.0K | $95.0K | $79.0K | $23.0K | $19.0K | $6.0K | |
| Other Non-op | $70.0K | $82.0K | $83.0K | $84.0K | $60.0K | $35.0K | $29.0K | $54.0K | $-3M | $-189.0K | $-220.0K | $6.0K | |
| Pretax Income | $-3M | $-3M | $-7M | $-3M | $-3M | $-3M | $-3M | $-3M | $-5M | $-3M | $-6M | $-865.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-3M | $-3M | $-7M | $-3M | $-3M | $-3M | $-3M | $-3M | $-15M | $-3M | $-6M | $-865.0K | |
| EPS (Basic) | $0.49 | $-0.36 | $-1.38 | $-1.07 | $-0.53 | $-1.46 | $-2.27 | $-2.20 | $-2.90 | $-3.07 | $-8.78 | $-0.07 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | $-0.23 | · | · | |
| Shares (Basic) | -10,255,917 | 8,955,809 | 5,411,709 | 3,105,156 | -2,545,213 | 1,851,910 | 1,234,305 | 1,225,423 | -13,545,760 | 1,014,036 | 687,840 | 12,884,604 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | 13,799,170 | · | · | |
| EBITDA | · | $-3M | $-8M | $-3M | · | $-3M | $-3M | $-3M | · | $-3M | · | · |
Balanço Patrimonial 19
| Métrica | Tendência | Q4 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $10M | $7M | $9M | $9M | $12M | $5M | $7M | $9M | $1M | · | · | |
| Other Current Assets | $577.0K | $257.0K | $416.0K | $389.0K | $473.0K | $109.0K | $199.0K | $325.0K | $783.0K | $467.0K | · | · | |
| Current Assets | $8M | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| PP&E (Net) | $19.0K | $20.0K | $16.0K | $19.0K | $21.0K | $20.0K | $17.0K | $19.0K | $16.0K | $14.0K | · | · | |
| Total Assets | $8M | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| Accounts Payable | $700.0K | $714.0K | $842.0K | $815.0K | $676.0K | $232.0K | $574.0K | $287.0K | $492.0K | $663.0K | · | · | |
| Accrued Liabilities | $1M | $936.0K | $645.0K | $1M | $1M | $881.0K | $683.0K | $476.0K | $285.0K | $310.0K | · | · | |
| Short-term Debt | · | · | · | · | · | $1M | · | · | · | · | · | · | |
| Current Liabilities | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $763.0K | $777.0K | $973.0K | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | $5M | · | · | |
| Total Liabilities | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $7M | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Total Debt | · | · | · | · | · | $1M | · | · | · | · | · | · | |
| Common Stock | $11.0K | $11.0K | $6.0K | $4.0K | $2.0K | $2.0K | $1.0K | $19.0K | $1.0K | $14.0K | · | · | |
| Paid-in Capital | $73M | $73M | $68M | $61M | $58M | $57M | $48M | $47M | $47M | $28M | · | · | |
| Retained Earnings | $-67M | $-64M | $-61M | $-54M | $-50M | $-47M | $-44M | $-42M | $-39M | $-34M | · | · | |
| Stockholders' Equity | $6M | $9M | $6M | $7M | $8M | $10M | $3M | $5M | $8M | $-6M | · | · | |
| Liabilities + Equity | $8M | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| Shares Outstanding | 11,409,344 | 11,409,344 | 6,194,147 | 4,022,625 | 2,497,033 | 2,462,983 | 1,152,120 | 19,242,081 | 942,575 | 14,430,221 | · | · |
Fluxo de Caixa 11
| Métrica | Tendência | Q4 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.0K | $4.0K | $2.0K | $3.0K | $48.0K | $47.0K | $45.0K | $43.0K | $81.0K | $35.0K | $0 | $0 | |
| Stock-based Comp | $1.0K | $2.0K | $138.0K | $388.0K | $405.0K | $418.0K | $445.0K | $360.0K | $618.0K | $212.0K | $151.0K | $0 | |
| Other Non-cash | · | · | · | $342.0K | · | · | · | $444.0K | · | · | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-4M | $-3M | $-3M | $-2M | $-2M | $-2M | $-7M | $-3M | $-1M | $-661.0K | |
| CapEx | $3.0K | $7.0K | $0 | $0 | $4.0K | $5.0K | $0 | $5.0K | $19.0K | $16.0K | $0 | $0 | |
| Investing Cash Flow | $-3.0K | $-7.0K | $0 | $0 | $-4.0K | $-5.0K | $0 | $-5.0K | $-19.0K | $-16.0K | $0 | $0 | |
| Stock Issued | · | · | · | · | $2.0K | $0 | $0 | $0 | · | $0 | $0 | $3M | |
| Net Stock Activity | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $-35.0K | $5M | $3M | $2M | $-174.0K | $9M | $0 | $0 | $14M | $2M | $350.0K | $3M | |
| Net Change in Cash | $-3M | $2M | $-1M | $-547.0K | $-3M | $7M | $-2M | $-2M | $8M | $-927.0K | $-794.0K | $2M | |
| Free Cash Flow | · | · | · | $-3M | · | · | · | $-2M | · | · | · | · |
Lucratividade 3
| Métrica | Tendência | Q4 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -29.4% | -112.0% | -41.5% | · | -39.4% | -104.5% | -76.1% | · | -344.2% | · | · | |
| ROE | · | -35.7% | -157.3% | -54.2% | · | -131.9% | -185.4% | -102.1% | · | 111.3% | · | · | |
| ROIC | · | -39.1% | -116.9% | -48.6% | · | -25.3% | -93.7% | -52.0% | · | 52.3% | · | · |
Liquidez e Solvência 4
| Métrica | Tendência | Q4 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 6.2 | 5.3 | 4.6 | · | 5.3 | 4.3 | 9.3 | · | 1.7 | · | · | |
| Quick Ratio | · | 6.0 | 5.0 | 4.4 | · | 5.3 | 4.1 | 8.8 | · | 1.3 | · | · | |
| Debt / Equity | · | · | · | · | · | 0.1 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -88.6 | · | · |
Eficiência 1
| Métrica | Tendência | Q4 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Avaliação (TTM) 9
| Métrica | Tendência | Q4 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | |
| Net Income TTM | · | $-25M | $-25M | $-20M | · | $-24M | $-24M | $-27M | · | $-11M | · | · | |
| Market Cap | · | $6M | $7M | $6M | · | $9M | $14M | $369M | · | · | · | · | |
| Enterprise Value | · | · | · | · | · | $-1M | · | · | · | · | · | · | |
| P/B | · | 0.7 | 1.0 | 0.9 | · | 1.0 | 4.6 | 69.9 | · | · | · | · | |
| P / Tangible Book | · | 0.7 | 1.0 | 0.9 | · | 1.0 | 4.6 | 69.9 | · | · | · | · | |
| P / Cash Flow | · | · | · | -2.4 | · | · | · | -199.5 | · | · | · | · | |
| P / FCF | · | · | · | -2.4 | · | · | · | -198.9 | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | 0.5 | · | · | · | · | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | |
|---|---|---|---|---|
| Receita | $0 | $0 | $0 | $0 |
| Lucro líquido | $-17M | $-11M | $-15M | $-2M |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.